Assistant Professor, Internal Medicine, University of Michigan Medical School
Gastroenterology
Dr. Elizabeth K. Speliotes, MD
|
|
Give Review
Elizabeth K. Speliotes, MD practices Gastroenterology. She went to Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1 in research and 12 in primary care medicine She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Elizabeth K. Speliotes is also published. She has 32 publications published. The lastest publication: "Population genetic differentiation of height and body mass index across Europe.' Elizabeth Speliotes accepts all Medicare patients.
Publications
- Population genetic differentiation of height and body mass index across Europe.
- TM6SF2: Catch-22 in the Fight Against Nonalcoholic Fatty Liver Disease and Cardiovascular Disease?
- Hepatic Steatosis and Cardiovascular Disease Outcomes: An Analysis of the Framingham Heart Study.
- New genetic loci link adipose and insulin biology to body fat distribution.
- Genetic studies of body mass index yield new insights for obesity biology.
- Empirical characteristics of family-based linkage to a complex trait: the ADIPOQ region and adiponectin levels.
- Erratum to: Empirical characteristics of family-based linkage to a complex trait: the ADIPOQ region and adiponectin levels.
- Genome-Wide Family-Based Linkage Analysis of Exome Chip Variants and Cardiometabolic Risk.
- Genome-wide association of body fat distribution in african ancestry populations suggests new Loci.
- Genetic Variation at NCAN Locus Is Associated with Inflammation and Fibrosis in Non-Alcoholic Fatty Liver Disease in Morbid Obesity.
- A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry.
- Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.
- Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study.
- Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B with Ultrasound-Defined Steatosis Based on Data from the NHANES III.
- Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile.
- Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution.
- Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.
- Genetics of common obesity and nonalcoholic fatty liver Disease.
- Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.
- Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.
- Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study.
- Common variants near MC4R are associated with fat mass, weight and risk of obesity.
- Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
- The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone.
- Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver Disease that have distinct effects on metabolic traits.
- Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.
- Hundreds of variants clustered in genomic loci and biological pathways affect human height.
- PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver Disease but not metabolic Disease.
- Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution.
- Common body mass index-associated variants confer risk of extreme obesity.
- Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.
Schools
Harvard Medical School
Massachusetts General Hospital
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1104809623 | |
| NPPES Provider LastName | SPELIOTES | |
| NPPES Provider FirstName | ELIZABETH | |
| NPPES Provider ZIPCode | 481095362 | |
| NPPES Provider State | MI | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 27.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104809623 |
| Last Name Of The Provider | SPELIOTES |
| First Name Of The Provider | ELIZABETH |
| View All |
Similar Doctors
|
|
Dr. Zhenglun Zhu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter W. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel B. Mason, MD
This Doctor is OpenDoctor Recommended.
|